Combined Analysis of CSF Tau, Aβ42, Aβ1-42% and Aβ1-40% in Alzheimer's Disease, Dementia with Lewy Bodies and Parkinson's Disease Dementia.
about
Dementia with lewy bodies: diagnosis and management for primary care providers.Neurochemical biomarkers in Alzheimer's disease and related disorders.MicroRNA-135b has a neuroprotective role via targeting of β-site APP-cleaving enzyme 1.Biological confounders for the values of cerebrospinal fluid proteins in Parkinson's disease and related disorders.Differential role of CSF fatty acid binding protein 3, α-synuclein, and Alzheimer's disease core biomarkers in Lewy body disorders and Alzheimer's dementia.Dementia with Lewy bodies and Parkinson's disease-dementia: current concepts and controversies.
P2860
Combined Analysis of CSF Tau, Aβ42, Aβ1-42% and Aβ1-40% in Alzheimer's Disease, Dementia with Lewy Bodies and Parkinson's Disease Dementia.
description
2010 nî lūn-bûn
@nan
2010 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Combined Analysis of CSF Tau, ...... Parkinson's Disease Dementia.
@ast
Combined Analysis of CSF Tau, ...... Parkinson's Disease Dementia.
@en
Combined Analysis of CSF Tau, ...... Parkinson's Disease Dementia.
@nl
type
label
Combined Analysis of CSF Tau, ...... Parkinson's Disease Dementia.
@ast
Combined Analysis of CSF Tau, ...... Parkinson's Disease Dementia.
@en
Combined Analysis of CSF Tau, ...... Parkinson's Disease Dementia.
@nl
prefLabel
Combined Analysis of CSF Tau, ...... Parkinson's Disease Dementia.
@ast
Combined Analysis of CSF Tau, ...... Parkinson's Disease Dementia.
@en
Combined Analysis of CSF Tau, ...... Parkinson's Disease Dementia.
@nl
P2093
P2860
P50
P356
P1476
Combined Analysis of CSF Tau, ...... Parkinson's Disease Dementia.
@en
P2093
Hermann Esselmann
Markus Otto
Mirko Bibl
Piotr Lewczuk
P2860
P304
12701-12711
P356
10.4061/2010/761571
P577
2010-08-24T00:00:00Z